Liver fibrosis and repair: immune regulation of wound healing in a solid organ
The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Abstract
Fibrosis is a highly conserved and co-ordinated protective response to tissue injury. The interaction of multiple pathways, molecules and systems determines whether fibrosis is self-limiting and homeostatic, or whether it is uncontrolled and excessive. Immune cells have been identified as key players in this fibrotic cascade, with the capacity to exert either injury-inducing or repair-promoting effects. A multi-organ approach was recently suggested to identify the core and regulatory pathways in fibrosis, with the aim of integrating the wealth of information emerging from basic fibrosis research. In this Review, we focus on recent advances in liver fibrosis research as a paradigm for wound healing in solid organs and the role of the immune system in regulating and balancing this response.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This pro-resolution macrophage phenotype drives ECM degradation, with upregulation of matrix metalloproteinase (MMP) expression and downregulation of the inflammatory transcriptome, including decreased expression levels of TGFβ1.[69], [70], [71]”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [71]
In the citing paper
“These infiltrating monocyte-derived macrophages can promote both fibrogenesis71 and fibrosis resolution.72,73”
From An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH (2023) · cites this paper as [72]
Citations
Cites
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873
Fate Mapping Reveals Origins and Dynamics of Monocytes and Tissue Macrophages under Homeostasis
Yona, S., Kim, K.-W., Wolf, Y., Mildner, A., Varol, D., Breker, M., Strauss-Ayali, D., Viukov, S., Guilliams, M., Misharin, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2012.12.001 · Cited by 3,245
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
TLR4 enhances TGF-β signaling and hepatic fibrosis
Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942
Marcellin, P., Gane, E., Buti, M., Afdhal, N., Sievert, W., Jacobson, I. M., Washington, M. K., Germanidis, G., Flaherty, J. F., Schall, R. A., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61425-1 · Cited by 1,788
Fibrotic disease and the TH1/TH2 paradigm
Wynn, T. A. (2004) · Nature Reviews Immunology · doi:10.1038/nri1412 · Cited by 1,765
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
Duffield, J. S., Forbes, S. J., Constandinou, C. M., Clay, S., Partolina, M., Vuthoori, S., Wu, S., Lang, R., & Iredale, J. P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522675 · Cited by 1,649
Self-citationBataller, R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524282c1 · Cited by 1,472
Macrophages: master regulators of inflammation and fibrosis
Wynn, T., & Barron, L. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1255354 · Cited by 1,392
Cited by
Items 101–121 of 121
Su, S.-B., Qin, S.-Y., Xian, X.-L., Huang, F.-F., Huang, Q.-L., ZhangDi, H.-J., & Jiang, H.-X. (2021) · Life Sciences · doi:10.1016/j.lfs.2020.118677 · Cited by 40
The Matrisome, Inflammation, and Liver Disease
Dolin, C. E., & Arteel, G. E. (2020) · Seminars in Liver Disease · doi:10.1055/s-0039-3402516 · Cited by 38
Wu, P., Luo, X., Wu, H., Zhang, Q., Dai, Y., & Sun, M. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120311 · Cited by 37
Macrophages as a Cell-Based Therapy for Liver Disease
Starkey Lewis, P. J., Moroni, F., & Forbes, S. J. (2019) · Seminars in Liver Disease · doi:10.1055/s-0039-1688502 · Cited by 36
Functional heterogeneity of CD4+ T cells in liver inflammation
Muscate, F., Woestemeier, A., & Gagliani, N. (2021) · Seminars in Immunopathology · doi:10.1007/s00281-021-00881-w · Cited by 32
Shrestha, S., Jeon, J.-H., & Hong, C.-W. (2025) · BMB Reports · doi:10.5483/bmbrep.2024-0058 · Cited by 30
“Activated by hepatic inflammation, KCs and HSCs can release chemokines and pro-inflammatory cytokines, which subsequently recruit and activate circulating innate immune cells such as neutrophils and monocytes (43-45).”
Chen, Q., Bao, L., Lv, L., Xie, F., Zhou, X., Zhang, H., & Zhang, G. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-4602 · Cited by 27
“However, few treatment options are currently available (5-8) and therefore, the development of new therapeutic drugs for liver fibrosis, along with an understanding of the molecular mechanisms involved, is vitally important.”
Chen, P., Zhou, Y.-K., Han, C.-S., Chen, L.-J., Wang, Y.-M., Zhuang, Z.-M., Lin, S., Zhou, Y.-H., Jiang, J.-H., & Yang, R.-L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.860225 · Cited by 25
Survival of endogenous hepatic stem/progenitor cells in liver tissues during liver cirrhosis
Chen, Q., You, X., Yang, W., Jiang, S., Lai, J., Zhang, H., & Bai, L. (2020) · Life Sciences · doi:10.1016/j.lfs.2019.117121 · Cited by 23
Advancements in MAFLD Modeling with Human Cell and Organoid Models
Wang, S.-X., Yan, J.-S., & Chan, Y.-S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911850 · Cited by 22
Future mechanistic strategies for tackling fibrosis–an unmet need in liver disease
Fallowfield, J. A. (2015) · Clinical Medicine · doi:10.7861/clinmedicine.15-6-s83 · Cited by 15
Self-citationZhang, R., Kikuchi, A. T., Nakao, T., Russell, J. O., Preziosi, M. E., Poddar, M., Singh, S., Bell, A. W., England, S. G., & Monga, S. P. (2019) · Gene Expression · doi:10.3727/105221618x15373858350141 · Cited by 15
Angiocrine Signaling in Sinusoidal Health and Disease
Cooper, S. A., Kostallari, E., & Shah, V. H. (2023) · Seminars in Liver Disease · doi:10.1055/a-2128-5907 · Cited by 15
Pinheiro, D., Leirós, L., Dáu, J. B. T., Stumbo, A. C., Thole, A. A., Cortez, E. A. C., Mandarim-de-Lacerda, C. A., Carvalho, L. D., & Carvalho, S. N. D. (2017) · PLOS ONE · doi:10.1371/journal.pone.0187970 · Cited by 13
Fu, R., Zu, S.-J., Liu, Y.-J., Li, J.-C., Dang, W.-Z., Liao, L.-P., Liu, L.-P., Chen, P.-Y., Huang, H.-M., Wu, K.-H., et al. (2022) · Bioengineered · doi:10.1080/21655979.2022.2066756 · Cited by 12
Jia, H., Ding, L., Yu, A., Tang, W., Tang, S., Zhang, C., & Oupický, D. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.07.018 · Cited by 12
Protozoan‐Derived Cytokine‐Transgenic Macrophages Reverse Hepatic Fibrosis
Chen, Y., Wang, J., Zhou, N., Fang, Q., Cai, H., Du, Z., An, R., Liu, D., Chen, X., Wang, X., et al. (2024) · Advanced Science · doi:10.1002/advs.202308750 · Cited by 12
TNC‑targeted CAR‑macrophage therapy alleviates liver fibrosis in mice
Chen, K., Lin, Z., Chen, L., Zhou, Y., Zhang, W., Wan, H., Huo, Y., Fu, Q., Gao, Z., Cheng, H., et al. (2025) · Military Medical Research · doi:10.1186/s40779-025-00667-3 · Cited by 11
“If not treated on time, all patients with chronic liver disease progress to advanced fibrosis, resulting in decompensated cirrhosis or the development of hepatocellular carcinoma, eventually increasing the risk of liver-related mortality [1].”
Che, T., Yang, X., Zhang, Y., Zheng, Y., Zhang, Y., Zhang, X., & Wu, Z. (2024) · Small · doi:10.1002/smll.202400413 · Cited by 8
Targeting macrophages in liver fibrosis
González del Barrio, L., Ipsen, D. H., Pfister, D. R., Hancz, D., & Scott, C. L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1835489 · Cited by 3
A high-throughput microphysiological system to quantify key events leading to liver fibrosis
Schmidt, S., & Suter-Dick, L. (2025) · Toxicology · doi:10.1016/j.tox.2025.154248 · Cited by 3
Metadata
- Authors
- Pellicoro, A., Ramachandran, P., Iredale, J. P., & Fallowfield, J. A.
- Affiliations
- Centre for Inflammation Research (GB)
- Corresponding author
- Fallowfield, Jonathan A.
- Venue
- Nature Reviews Immunology
- Published
- 2014-02-25
- Volume
- 14
- Issue
- 3
- Pages
- 181-194
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2069819211
- Cited by
- 1,310
- References
- 114
- Citations by year
- 2026: 63 · 2025: 86 · 2024: 108 · 2023: 121 · 2022: 114 · 2021: 139 · 2020: 125 · 2019: 129 · 2018: 100 · 2017: 117 · 2016: 92 · 2015: 95 · 2014: 17
- FWCI
- 13.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Medical Research Council (MR/J010766/1)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Surgery › Wound Healing and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- liver fibrosis, tissue repair, wound healing, macrophage subsets, immune regulation, tissue homeostasis, tissue damage, solid organs
- MeSH terms
- Animals, Dendritic Cells, Fibrosis, Humans, Inflammation, Liver, Liver Cirrhosis, Macrophages, Wound Healing, Th1 Cells, Th2 Cells, T-Lymphocytes, Regulatory, Mice, Hepatic Stellate Cells, Natural Killer T-Cells, Th17 Cells, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.